X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (961) 961
Newsletter (13) 13
Magazine Article (3) 3
Book Chapter (2) 2
Conference Proceeding (2) 2
Book / eBook (1) 1
Newspaper Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (612) 612
fosfomycin (488) 488
fosfomycin - administration & dosage (396) 396
index medicus (353) 353
female (323) 323
male (298) 298
fosfomycin - therapeutic use (285) 285
pharmacology & pharmacy (225) 225
anti-bacterial agents - therapeutic use (223) 223
infectious diseases (221) 221
microbiology (206) 206
fosfomycin - pharmacology (205) 205
adult (201) 201
middle aged (197) 197
anti-bacterial agents - administration & dosage (194) 194
anti-bacterial agents - pharmacology (188) 188
antibiotics (186) 186
microbial sensitivity tests (180) 180
aged (169) 169
animals (162) 162
urinary tract infections - drug therapy (140) 140
infections (118) 118
escherichia-coli (107) 107
urinary tract infections (107) 107
treatment outcome (102) 102
administration, oral (99) 99
fosfomycin - pharmacokinetics (96) 96
adolescent (95) 95
health aspects (90) 90
drug resistance (83) 83
drug therapy, combination (79) 79
research (76) 76
urinary tract infections - microbiology (75) 75
bacteria (74) 74
dosage and administration (74) 74
drug administration schedule (74) 74
drug resistance in microorganisms (71) 71
antimicrobial agents (69) 69
fosfomycin - adverse effects (69) 69
child (67) 67
pharmacokinetics (67) 67
biochemical phenomena, metabolism, and nutrition (66) 66
anti-bacterial agents - pharmacokinetics (65) 65
bacterial infections - drug therapy (64) 64
resistance (63) 63
time factors (62) 62
drug resistance, multiple, bacterial (61) 61
in-vitro activity (61) 61
aged, 80 and over (59) 59
drug resistance, bacterial (59) 59
drug therapy (59) 59
escherichia coli - drug effects (56) 56
rats (55) 55
drug synergism (54) 54
urinary tract infection (54) 54
urinary-tract-infections (54) 54
care and treatment (53) 53
klebsiella-pneumoniae (53) 53
analysis (52) 52
colistin (52) 52
escherichia coli infections - drug therapy (52) 52
fosfomycin - metabolism (51) 51
multidrug-resistant (51) 51
tigecycline (51) 51
ciprofloxacin (50) 50
e coli (50) 50
pharmacology (49) 49
immunology (48) 48
child, preschool (47) 47
nitrofurantoin (47) 47
anti-bacterial agents - adverse effects (45) 45
critically-ill patients (45) 45
injections, intravenous (45) 45
medicine & public health (45) 45
susceptibility (44) 44
fosfomycin - blood (43) 43
internal medicine (43) 43
staphylococcal infections - drug therapy (43) 43
antimicrobial resistance (42) 42
enterobacteriaceae (42) 42
escherichia coli (42) 42
infectious disease (42) 42
oncology (42) 42
antibacterial agents (41) 41
infection (41) 41
vancomycin (41) 41
cystitis (40) 40
dose-response relationship, drug (40) 40
pathogens (40) 40
pseudomonas aeruginosa - drug effects (40) 40
therapy (40) 40
epidemiology (39) 39
pseudomonas-aeruginosa (39) 39
drug combinations (38) 38
infant (38) 38
fosfomycin trometamol (37) 37
antibiotic resistance (36) 36
antimicrobial susceptibility (36) 36
efficacy (36) 36
urinary tract (36) 36
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (839) 839
Japanese (100) 100
French (27) 27
Italian (24) 24
German (18) 18
Russian (10) 10
Spanish (10) 10
Dutch (3) 3
Bulgarian (2) 2
Arabic (1) 1
Chinese (1) 1
Danish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2014, Volume 58, Issue 3, pp. 1757 - 1762
Journal Article
Expert review of anti-infective therapy, ISSN 1744-8336, 2014, Volume 6, Issue 5, pp. 593 - 600
Despite the constantly increasing need for new antimicrobial agents, antibiotic drug discovery and development seem to have greatly decelerated in recent... 
aminoglycoside | Acinetobacter baumannii | multiple-drug resistant | fusidic acid | polymyxin B | Pseudomonas aeruginosa | chloramphenicol | fosfomycin | colistin | Colistin | Aminoglycoside | Fusidic acid | Chloramphenicol | Polymyxin B | Fosfomycin | Multiple-drug resistant | VENTILATOR-ASSOCIATED PNEUMONIA | NATURAL-PRODUCTS | RESISTANT STAPHYLOCOCCUS-AUREUS | ANTIBACTERIAL DRUG DISCOVERY | GRAM-NEGATIVE BACTERIA | INTENSIVE-CARE-UNIT | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | CYSTIC-FIBROSIS | CRITICALLY-ILL PATIENTS | TRIMETHOPRIM-SULFAMETHOXAZOLE | Fusidic Acid - administration & dosage | Humans | Drug Resistance, Bacterial | Drug Utilization | Anti-Bacterial Agents - therapeutic use | Aminoglycosides - administration & dosage | Colistin - therapeutic use | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Fosfomycin - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Bacterial Infections - drug therapy | Fosfomycin - adverse effects | Colistin - administration & dosage | Fusidic Acid - adverse effects | Chloramphenicol - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Fusidic Acid - therapeutic use | Chloramphenicol - adverse effects | Anti-Bacterial Agents - classification | Fosfomycin - administration & dosage | Aminoglycosides - adverse effects | Anti-Bacterial Agents - administration & dosage | Aminoglycosides - therapeutic use | Chloramphenicol - administration & dosage | Drug resistance in microorganisms | Pseudomonas aeruginosa infections | Usage | Antibiotics | Research | Drug therapy | Health aspects | Risk factors | Index Medicus
Journal Article
BMC infectious diseases, ISSN 1471-2334, 2018, Volume 18, Issue 1, pp. 626 - 8
BACKGROUND: Febrile Urinary Tract Infection (FUTI) is frequently treated initially with intravenous antibiotics, followed by oral antibiotics guided by... 
Anti-Bacterial Agents/administration & dosage | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Escherichia coli Infections/complications | Fosfomycin/administration & dosage | Escherichia coli/drug effects | Young Adult | Administration, Intravenous | Fever/complications | Urinary Tract Infections/complications | Adolescent | Aged, 80 and over | Placebos | Adult | Female | Aged | Equivalence Trials as Topic | Ciprofloxacin/administration & dosage | INFECTIOUS DISEASES | Randomized clinical trial | ESCHERICHIA-COLI | SUSCEPTIBILITY | GUIDELINES | Antibiotic treatment | Scherichia coli | RESISTANT | Urinary tract infection | THERAPY | PYELONEPHRITIS | LEVOFLOXACIN | Fosfomycin-trometamol | SWITCH | Escherichia coli - drug effects | Fever - complications | Urinary Tract Infections - complications | Anti-Bacterial Agents - adverse effects | Escherichia coli Infections - drug therapy | Ciprofloxacin - adverse effects | Fosfomycin - adverse effects | Urinary Tract Infections - drug therapy | Fosfomycin - administration & dosage | Ciprofloxacin - administration & dosage | Anti-Bacterial Agents - administration & dosage | Fever - drug therapy | Escherichia coli Infections - complications | Drug resistance in microorganisms | Usage | Analysis | Mortality | Urinary tract infections | Chemical properties | Ciprofloxacin | Health aspects | Fosfomycin | Intravenous administration | Clinical trials | Population studies | Systematic review | Infections | Urinary tract | Absenteeism | Drug resistance | Trometamol | Randomization | Pain | E coli | Bacteria | Urogenital system | Electrical impedance | Urine | Women | Bacterial infections | Antimicrobial agents | Patients | Bactericidal activity | Urinary tract diseases | Antibiotics | Internet
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2014, Volume 58, Issue 3, pp. 1284 - 1293
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 02/2013, Volume 11, Issue 2, pp. 159 - 177
The increasing incidence of carbapenem-resistant Klebsiella pneumoniae (CR-KP) fundamentally alters the management of patients at risk to be colonized or... 
carbapenem-resistant Klebsiella pneumoniae | carbapenemase-producing strains | combination antimicrobial therapy | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | RISK-FACTORS | VENTILATOR-ASSOCIATED PNEUMONIA | ACUTE-CARE FACILITIES | COMBINATION THERAPY | MICROBIOLOGY | METALLO-BETA-LACTAMASE | COLISTIN METHANESULFONATE | PSEUDOMONAS-AERUGINOSA | MOLECULAR EPIDEMIOLOGY | PHARMACOLOGY & PHARMACY | CRITICALLY-ILL PATIENTS | Klebsiella pneumoniae - drug effects | Minocycline - pharmacology | Carbapenems - administration & dosage | Humans | Minocycline - analogs & derivatives | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Carbapenems - pharmacology | Colistin - pharmacology | Aminoglycosides - administration & dosage | Minocycline - therapeutic use | Colistin - therapeutic use | Minocycline - administration & dosage | Rifampin - therapeutic use | Rifampin - administration & dosage | Drug Therapy, Combination | Fosfomycin - therapeutic use | Klebsiella Infections - drug therapy | Fosfomycin - pharmacology | Risk Factors | Colistin - administration & dosage | Carbapenems - therapeutic use | Fosfomycin - administration & dosage | Anti-Bacterial Agents - pharmacology | Rifampin - pharmacology | Aminoglycosides - pharmacology | Anti-Bacterial Agents - administration & dosage | Aminoglycosides - therapeutic use | Klebsiella | Care and treatment | Usage | Antibiotics | Research | Carbapenems | Drug resistance | Health aspects
Journal Article
Pharmacological research, ISSN 1043-6618, 2008, Volume 57, Issue 2, pp. 125 - 131
...), methionine and taurine. Mice were supplemented by gavage with various combinations of agents as designed in the orthogonal table once a day for nine days beginning two days before cisplatin administration... 
Oxidative stress | Side effects | Hepatotoxicity | Cisplatin | Protective agents | INDUCED APOPTOSIS | PROTEIN-KINASE | INDUCED TOXICITY | SODIUM THIOSULFATE | ALPHA-TOCOPHEROL | N-ACETYLCYSTEINE | INDUCED HEARING-LOSS | protective agents | D-METHIONINE | hepatotoxicity | INDUCED OXIDATIVE STRESS | side effects | PHARMACOLOGY & PHARMACY | INDUCED NEPHROTOXICITY | cisplatin | oxidative stress | Thiosulfates - therapeutic use | Zinc - administration & dosage | Glutathione - metabolism | Male | Alanine Transaminase - blood | Antineoplastic Agents - administration & dosage | Methionine - therapeutic use | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Acetylcysteine - therapeutic use | Acetylcysteine - administration & dosage | Drug Therapy, Combination | Taurine - therapeutic use | Chemical and Drug Induced Liver Injury - etiology | Malondialdehyde - metabolism | Chemical and Drug Induced Liver Injury - prevention & control | Fosfomycin - therapeutic use | Injections, Intraperitoneal | Methionine - administration & dosage | Zinc - therapeutic use | Selenium - therapeutic use | Antioxidants - therapeutic use | Pilot Projects | Animals | Fosfomycin - administration & dosage | Antioxidants - administration & dosage | Cisplatin - adverse effects | Thiosulfates - administration & dosage | Mice | Taurine - administration & dosage | Selenium - administration & dosage | Methionine | Glutathione | Index Medicus
Journal Article
Journal of Korean medical science, ISSN 1598-6357, 2014, Volume 29, Issue 8, pp. 1178 - 1181
Journal Article
Critical Care Medicine, ISSN 0090-3493, 06/2019, Volume 47, Issue 6, pp. e470 - e477
Journal Article
Scientific reports, ISSN 2045-2322, 2019, Volume 9, Issue 1, pp. 6727 - 8
We aimed to investigate the safety of intraperitoneal administration of the combination of fosfomycin, metronidazole, and recombinant human granulocyte-macrophage colony-stimulating factor (rhGMCSF... 
MORTALITY | DIAGNOSIS | ROUTE | PHARMACOKINETICS | MORBIDITY | MULTIDISCIPLINARY SCIENCES | INFECTION | INTRAVENOUS FOSFOMYCIN | GENTAMICIN | Appendectomy | Granulocyte-macrophage colony-stimulating factor | Colonies | Appendicitis | Diarrhea | Clinical trials | Laparoscopy | Patients | Fosfomycin | Granulocytes | Surgery | Anesthesia | Colony-stimulating factor | Metronidazole | Biochemical markers
Journal Article